Sunflower Pharmaceutical Group (002737.SZ): Pediatric pulmonary heat cough and wheezing oral solution approved for clinical trials.
Sunflower Pharmaceutical Industry (002737.SZ) announced that its wholly-owned subsidiary, Heilongjiang Sunflower Pharmaceutical Co., Ltd., recently...
Sunflower Pharmaceutical Group (002737.SZ) announced that its wholly-owned subsidiary, Heilongjiang Sunflower Pharmaceutical Group Co., Ltd., recently received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for the oral solution of pediatric pulmonary heat and cough asthma, allowing the product to conduct clinical trials for acute bronchitis in children.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
